Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000599058 | SCV000710068 | pathogenic | not provided | 2022-11-25 | criteria provided, single submitter | clinical testing | Identified in a patient and his parent, each with early childhood febrile seizures, in published literature (Della Mina et al., 2015); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 24848745) |
Labcorp Genetics |
RCV001854122 | SCV002246015 | pathogenic | Epilepsy, childhood absence 2; Febrile seizures, familial, 8 | 2021-07-13 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Ala118Cysfs*6) in the GABRG2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GABRG2 are known to be pathogenic (PMID: 22539854, 22750526, 24407264). This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with febrile seizures (PMID: 24848745). ClinVar contains an entry for this variant (Variation ID: 503773). |
Génétique des Maladies du Développement, |
RCV004546529 | SCV005040955 | pathogenic | Seizure | 2024-03-04 | criteria provided, single submitter | clinical testing |